Status:
COMPLETED
Hyperprotein Nutritional Intervention in Elderly Patients With Hip Fracture and Sarcopenia
Lead Sponsor:
Hospital Viamed Valvanera, Spain
Collaborating Sponsors:
University of Navarra
Conditions:
Sarcopenia
Hip Fracture
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
1. RATIONALE The unique characteristic of our study lies in the attempt to reverse the functional impairment experienced by sarcopenic patients with hip fracture using nutritional intervention. What m...
Detailed Description
INTRODUCTION Sarcopenia is the loss of muscle mass and function associated to age. Rosemberg first spoke of sarcopenia in 1989. A progressive loss of muscle mass occurs from approximately 40 years of ...
Eligibility Criteria
Inclusion
- Patients aged 65 years or older
- Diagnosis of traumatic hip fracture
- Patients admitted for rehabilitation
- Patients signing informed consent.
Exclusion
- Stage 4 renal failure
- Child C stage hepatic insufficiency
- Barthel index \< 20 in the six months prior to admission
- Dysphagia for liquids
- Active oncological disease who are receiving treatment
- Severe clinical conditions compromising and threatening their lives
- Morbid obesity (BMI \> 40)
- BMI \< 21 kg/m2
- Albumin levels \< 2.1 g/dL
- MNA \< 11
- Charlson index ≥ 6
- diabetes mellitus
- Patients not doing rehabilitation.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01404195
Start Date
January 1 2012
End Date
December 1 2015
Last Update
February 5 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Los Manzanos
Logroño, La Rioja, Spain, 26140